Huntington Bancshares
HBAN
$16.76
+2.76%
Huntington Bancshares Inc. is a prominent regional bank operating in the U.S. financial services sector, offering a comprehensive suite of consumer and commercial banking services including deposit accounts, lending, payments, investment management, and treasury management. The company is a significant player in the Midwest, distinguished by its focus on relationship banking and a diversified commercial portfolio that includes specialized services like equipment financing and capital markets. The current investor narrative centers on the bank's performance in a challenging interest rate environment, with attention on its net interest margin trajectory, credit quality, and its ability to navigate economic uncertainty while returning capital to shareholders.…
HBAN
Huntington Bancshares
$16.76
Investment Opinion: Should I buy HBAN Today?
Rating: Hold. The core thesis is that HBAN is a fundamentally sound company caught in a sector-wide downdraft, presenting a value trap until technical and macro headwinds abate. This aligns with the generally supportive but cautious analyst sentiment reflected in reiterated positive ratings.
Supporting Evidence: The valuation is compelling, with a forward P/E of 8.61x and a PEG of 0.85 suggesting undervaluation. Profitability is strong, evidenced by a 15.98% net margin and $2.265B in annual FCF. The balance sheet is robust with a 0.76 D/E ratio, and the 3.96% dividend yield is well-covered by a 45.95% payout ratio. However, these positives are offset by a -5.48% 3-month price decline and persistent underperformance versus the broader market.
Risks & Conditions: The two biggest risks are a breakdown below the $14.19 technical support level and a sharper-than-expected decline in net interest margin. This Hold rating would upgrade to a Buy if the stock establishes a firm base above $15 and the forward P/E compresses further toward 8x on sustained earnings, or if the sector shows definitive signs of stabilization. It would downgrade to a Sell on a confirmed break below $14.19 or a deceleration in quarterly revenue growth toward 0%. The stock is fairly valued to slightly undervalued relative to its own history and bank sector peers, but the market is correctly pricing in significant cyclical and sector risks.
Sign up to view all
HBAN 12-Month Price Forecast
HBAN is a battleground stock where strong value fundamentals are losing to weak momentum and sector headwinds. The base case of range-bound trading is most likely, as the dividend and valuation provide a floor, but a catalyst for a sustained re-rating is absent. The stance would upgrade to Bullish on a confirmed reversal above the 200-day moving average and evidence of sequential NIM expansion. It would downgrade to Bearish on a break below the $14.19 support level, which would invalidate the value thesis and signal further technical deterioration.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Huntington Bancshares's 12-month outlook, with a consensus price target around $21.79 and implied upside of +30.0% versus the current price.
Average Target
$21.79
3 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
3
covering this stock
Price Range
$13 - $22
Analyst target range
Analyst coverage for HBAN appears limited in the provided dataset, with only 3 analysts contributing to estimates for revenue and EPS. This suggests the stock may have lower institutional coverage compared to mega-cap peers, which can lead to higher volatility and less efficient price discovery. The consensus leans bullish based on the available institutional ratings, which show a preponderance of 'Buy', 'Overweight', or 'Outperform' ratings from firms like DA Davidson, Truist Securities, Morgan Stanley, and JP Morgan, with only a few 'Market Perform', 'Equal Weight', or 'Underweight' ratings noted. The target price range implied by EPS estimates is wide, with a low estimate of $1.74 and a high of $2.35 for the next period, reflecting significant uncertainty or divergent views on the company's earnings power. The recent pattern of analyst actions shows no downgrades in the provided data, with all recent updates being reiterations of existing positive ratings, indicating stable and generally supportive sentiment among covering analysts despite the stock's price weakness.
Bulls vs Bears: HBAN Investment Factors
The evidence presents a classic value versus momentum conflict. The bull case is grounded in solid fundamentals: strong profitability, a healthy balance sheet, attractive valuation, and a high dividend yield. The bear case is driven by powerful technicals: a persistent downtrend, significant underperformance versus the market, and sector-wide headwinds. Currently, the bearish technical and macro evidence holds greater sway, as the stock price action reflects deep investor skepticism despite the cheap valuation. The single most important tension is whether the compelling valuation (forward P/E of 8.6x, P/B of 1.05) will attract value buyers to halt the downtrend, or if sector-wide fears and technical breakdown will push the stock to test its 52-week low of $14.19.
Bullish
- Strong Profitability and Cash Flow: HBAN maintains robust profitability with a Q4 2025 net margin of 15.98% and generated $2.265 billion in trailing-twelve-month free cash flow. This strong cash generation supports a sustainable 3.96% dividend yield and a conservative 45.95% payout ratio.
- Attractive Valuation Metrics: The stock trades at a forward P/E of 8.61x and a PEG ratio of 0.85, suggesting undervaluation relative to earnings growth. Its P/B ratio of 1.05 indicates it is priced near tangible book value, a level often considered a floor for bank stocks.
- Solid Financial Health: The company has a low debt-to-equity ratio of 0.76, indicating minimal leverage risk. A Return on Equity (ROE) of 9.08% is reasonable for the sector, and the balance sheet provides a stable foundation for navigating economic cycles.
- Stable, Diversified Revenue Growth: Revenue grew 5.8% YoY in Q4 2025, with contributions from fee-based segments like Cards & Payment Processing ($162M) and Trust & Investment Management ($101M). This diversification reduces reliance on pure net interest income.
Bearish
- Persistent Technical Downtrend: The stock is in a clear 6-month downtrend, trading 84% of the way toward its 52-week low. It has underperformed the S&P 500 by -17.88% over the past year, indicating sustained sector and stock-specific weakness.
- Valuation Compression and Peak Earnings Risk: The trailing P/E of 11.61x is below its historical average of 12.90x, reflecting market concerns over peak net interest margins. The wide analyst EPS range ($1.74-$2.35) signals significant uncertainty about future earnings power.
- Modest Growth in Challenging Macro Environment: While revenue grew 5.8% YoY, this is modest for a growth stock and may struggle to accelerate in a higher-for-longer rate environment. The bank's performance is highly sensitive to interest rate policy and economic uncertainty.
- Limited Analyst Coverage and High Short Interest: Only 3 analysts provide estimates, suggesting lower institutional interest and potentially less efficient price discovery. A short ratio of 2.46 indicates a notable bearish bet against the stock by short sellers.
HBAN Technical Analysis
The stock is in a clear downtrend over the past six months, having retreated significantly from its 52-week high. With a 1-year price change of +12.71%, the longer-term trend remains positive, but the current price of $16.40 sits at approximately 84% of its 52-week range (high: $19.46, low: $14.19), indicating it is much closer to the low end of its annual band and has given back most of its prior gains. This positioning near the lower bound suggests the stock is either presenting a value opportunity after a significant correction or is still in a phase of technical weakness, having failed to hold higher levels established earlier in the year. Recent momentum is mixed, with a 1-month gain of +5.53% suggesting a potential near-term rebound or stabilization, but this is overshadowed by a 3-month decline of -5.48%. This divergence, where short-term momentum is positive against a negative medium-term trend, could signal a potential trend reversal or a dead-cat bounce within a broader downtrend, especially given the stock's relative strength versus the S&P 500 has been negative across all measured periods, including a -17.88% underperformance over the past year. Key technical levels are clearly defined, with immediate support at the 52-week low of $14.19 and resistance at the 52-week high of $19.46. A decisive break below $14.19 would signal a continuation of the downtrend and likely trigger further selling, while a sustained move above the recent highs near $19 would be needed to invalidate the bearish structure. The stock's volatility, as implied by a maximum drawdown of -22.06% over the provided period, highlights its sensitivity to sector and macro headwinds, which is typical for regional banks.
Beta
0.97
0.97x market volatility
Max Drawdown
-22.1%
Largest decline past year
52-Week Range
$14-$19
Price range past year
Annual Return
+15.3%
Cumulative gain past year
| Period | HBAN Return | S&P 500 |
|---|---|---|
| 1m | +7.1% | +10.5% |
| 3m | -4.1% | +3.9% |
| 6m | +8.5% | +5.4% |
| 1y | +15.3% | +29.6% |
| ytd | -4.1% | +5.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
HBAN Fundamental Analysis
Revenue growth has been modest but positive, with Q4 2025 revenue of $3.247 billion representing a 5.8% year-over-year increase. The quarterly trend shows revenue climbing from $2.983 billion in Q1 2025 to the Q4 level, indicating sequential growth through the year. Segment data, though limited, shows contributions from fee-based businesses like Cards and Payment Processing ($162 million) and Trust and Investment Management ($101 million), which help diversify income away from pure net interest margin. This steady, single-digit growth trajectory reflects a stable core banking operation but lacks the explosive growth seen in other sectors, positioning HBAN as a steady, income-oriented investment. The company is solidly profitable, with Q4 2025 net income of $519 million and a net margin of 15.98%. Gross margin for the quarter was a healthy 63.17%, and the operating margin was 21.53%. Profitability has been consistent, with net income figures ranging from $527 million to $629 million across the four quarters of 2025. The payout ratio of 45.95% indicates a balanced approach to returning capital while retaining earnings for growth, supporting a dividend yield of approximately 3.96%. The balance sheet and cash flow position appear robust. The debt-to-equity ratio is a conservative 0.76, indicating a low reliance on debt financing. The company generated substantial free cash flow on a trailing-twelve-month basis of $2.265 billion. Return on Equity (ROE) stands at 9.08%, which is a reasonable level for a bank in the current environment. The strong free cash flow generation supports the dividend and provides flexibility for share repurchases or strategic investments, underpinning the company's financial health.
Quarterly Revenue
$3.2B
2025-12
Revenue YoY Growth
+0.05%
YoY Comparison
Gross Margin
+0.63%
Latest Quarter
Free Cash Flow
$2.3B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is HBAN Overvalued?
Given the company's consistent profitability with a positive net income, the primary valuation metric selected is the Price-to-Earnings (PE) ratio. The trailing PE ratio is 11.61x, while the forward PE is lower at 8.61x. This gap suggests the market anticipates earnings growth, as the forward multiple implies a discount based on higher expected future profits. The PEG ratio of 0.85, based on trailing metrics, further suggests the stock may be undervalued relative to its earnings growth rate. Compared to typical industry averages for regional banks, a trailing PE of ~11.6x appears to be in line or at a slight discount, as banks often trade at lower multiples than the broader market. The Price-to-Book (PB) ratio of 1.05 is a critical bank valuation metric and indicates the stock is trading just above its tangible book value, which is generally considered a reasonable level and not indicative of overvaluation. The Price-to-Sales (PS) ratio of 2.06 provides another cross-check, confirming the valuation is not stretched on a sales basis. Historically, the stock's own valuation has compressed. The current trailing PE of 11.61x is below the historical PE of 12.90x from Q4 2025 and has declined from levels above 18x seen in late 2023. This places the current valuation near the lower end of its recent historical range, which could signal a value opportunity if the company's fundamentals remain intact, or it may reflect market concerns about peak earnings and future net interest margin pressure in the banking sector.
PE
11.6x
Latest Quarter
vs. Historical
High-End
5-Year PE Range -268x~19x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
15.8x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: HBAN's primary financial risk is its sensitivity to interest rate policy, which directly impacts net interest margin—a key profit driver for banks. While the debt-to-equity ratio of 0.76 is low, earnings volatility is evident in the quarterly net income range of $519M to $629M in 2025. Revenue concentration in traditional banking makes growth dependent on loan demand and deposit costs, with modest 5.8% YoY growth offering limited cushion against a downturn. The valuation itself presents a risk if earnings decline, as the seemingly low P/E could expand rapidly.
Market & Competitive Risks: The stock trades at a discount to its own historical P/E (11.61x vs. 12.90x), but this 'value' may represent a permanent de-rating if the market anticipates structurally lower profitability for regional banks. Competitive disruption from fintech and larger national banks pressures fee income. The stock's high macro sensitivity is confirmed by its -22.06% maximum drawdown and consistent underperformance versus the S&P 500. A sustained sector rotation out of financials would exacerbate this weakness.
Worst-Case Scenario: The worst-case involves a hard economic landing triggering higher loan loss provisions, combined with a rapid Fed easing cycle that compresses net interest margins. This would lead to consecutive earnings misses, dividend sustainability concerns, and a full valuation derating. In this scenario, the stock could realistically re-test and break below its 52-week low of $14.19, representing a potential loss of approximately -13.5% from the current $16.40. A more severe bear case could see a drop toward book value, implying a further downside to the $15-$16 range.
FAQ
The key risks are, in order of severity: 1) Macro/Sector Risk: Sensitivity to interest rates and economic cycles, evidenced by the stock's -22.06% max drawdown and persistent underperformance. 2) Earnings Compression Risk: Net interest margin pressure could cause earnings to fall, making the low P/E ratio deceptive. 3) Technical Risk: The established downtrend could continue, pushing the stock toward its $14.19 52-week low. 4) Low Coverage Risk: With only 3 analysts providing estimates, the stock may suffer from lower liquidity and less institutional support, amplifying volatility.
The 12-month forecast presents three scenarios. The Base Case (60% probability) sees the stock trading between $16.50 and $18.50, as it remains range-bound with its dividend providing support. The Bull Case (25% probability) targets $19.00 to $20.50 on a sector re-rating and stable margins. The Bear Case (15% probability) risks a drop to $14.00-$15.50 if economic conditions worsen. The base case is most likely, assuming HBAN meets consensus EPS estimates of $2.12 and the regional bank sector does not deteriorate further. The wide analyst EPS range ($1.74-$2.35) underscores the high degree of uncertainty in any forecast.
HBAN stock is fairly valued to slightly undervalued based on standard metrics. Its forward P/E of 8.61x and PEG ratio of 0.85 suggest the market is pricing in low growth or potential earnings decline. The Price-to-Book ratio of 1.05 indicates it trades just above its tangible net asset value, a level typically considered a floor for banks. Compared to its own historical trailing P/E of 12.90x, the current 11.61x multiple represents a discount. The valuation implies the market expects stagnant earnings and carries a significant risk premium for sector headwinds, offering a margin of safety if those fears prove overblown.
HBAN is a good buy for a specific type of investor: one seeking high dividend income (3.96% yield) and willing to accept sector volatility for potential long-term value realization. The stock appears undervalued on a forward P/E basis (8.61x) and has strong fundamentals, including robust free cash flow and a clean balance sheet. However, it is not a good buy for short-term traders or those sensitive to momentum, as the stock is in a clear downtrend and has significantly underperformed the market. The attractive risk/reward emerges below $16 for patient investors, but timing the entry is challenging.
HBAN is suitable primarily for long-term investment (minimum 2-3 years). Its high dividend yield and value characteristics are geared toward total return over time, not short-term price appreciation. The stock's volatility (high short interest, sector sensitivity) and lack of a positive momentum catalyst make it a poor candidate for short-term trading. Long-term investors can collect the dividend while waiting for a potential valuation normalization. The low beta nature of its business (implied by its business model) supports a buy-and-hold strategy, but investors must be prepared for periods of significant drawdowns common to the banking sector.